News & Updates
Filter by Specialty:

Does lung biopsy worsen lung function, survival in IPF patients?
Surgical lung biopsy (SLB) neither reduces lung function nor increases the risk of death or lung transplantation in patients with idiopathic pulmonary fibrosis (IPF), reports a study.
Does lung biopsy worsen lung function, survival in IPF patients?
28 Jun 2024
KRYSTAL-12 boosts adagrasib as 2L Tx alternative for KRASG12C-mutated NSCLC
Findings from the phase III KRYSTAL-12 trial underpin the treatment potential of adagrasib for previously treated metastatic non-small cell lung cancer (NSCLC) harbouring a KRASG12C mutation.
KRYSTAL-12 boosts adagrasib as 2L Tx alternative for KRASG12C-mutated NSCLC
28 Jun 2024
Off-label targeted drugs improve survival in CTEPH
Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.
Off-label targeted drugs improve survival in CTEPH
26 Jun 2024
Working out in the COVID aftermath: How intense can one go?
Outpatients with post-COVID condition (PCC) generally tolerated exercise without significant worsening of symptoms or decline in aerobic performance after 48 hours. However, they had lower muscle strength and aerobic capacity than controls, and even showed signs of POTS* and myopathy in a randomized crossover trial.
Working out in the COVID aftermath: How intense can one go?
26 Jun 2024
Lung ultrasound helps rule out ILD in patients with RA
Lung ultrasound (LUS), a low-cost tool with a high negative predictive value, can be a useful instrument for dismissing the presence of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA), suggests a study.